These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 34654436)

  • 1. Neurofilament light: a possible prognostic biomarker for treatment of vascular contributions to cognitive impairment and dementia.
    Hoyer-Kimura C; Konhilas JP; Mansour HM; Polt R; Doyle KP; Billheimer D; Hay M
    J Neuroinflammation; 2021 Oct; 18(1):236. PubMed ID: 34654436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Angiotensin-(1-7) Glycosylated Mas Receptor Agonist for Treating Vascular Cognitive Impairment and Inflammation-Related Memory Dysfunction.
    Hay M; Polt R; Heien ML; Vanderah TW; Largent-Milnes TM; Rodgers K; Falk T; Bartlett MJ; Doyle KP; Konhilas JP
    J Pharmacol Exp Ther; 2019 Apr; 369(1):9-25. PubMed ID: 30709867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PNA5, A Novel Mas Receptor Agonist, Improves Neurovascular and Blood-Brain-Barrier Function in a Mouse Model of Vascular Cognitive Impairment and Dementia.
    Hoyer-Kimura C; Hay M; Konhilas JP; Morrison HW; Methajit M; Strom J; Polt R; Salcedo V; Fricks JP; Kalya A; Pires PW
    Aging Dis; 2024 Aug; 15(4):1927-1951. PubMed ID: 37815905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MarkVCID cerebral small vessel consortium: I. Enrollment, clinical, fluid protocols.
    Wilcock D; Jicha G; Blacker D; Albert MS; D'Orazio LM; Elahi FM; Fornage M; Hinman JD; Knoefel J; Kramer J; Kryscio RJ; Lamar M; Moghekar A; Prestopnik J; Ringman JM; Rosenberg G; Sagare A; Satizabal CL; Schneider J; Seshadri S; Sur S; Tracy RP; Yasar S; Williams V; Singh H; Mazina L; Helmer KG; Corriveau RA; Schwab K; Kivisäkk P; Greenberg SM;
    Alzheimers Dement; 2021 Apr; 17(4):704-715. PubMed ID: 33480172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex differences in the effects of high fat diet on underlying neuropathology in a mouse model of VCID.
    Abi-Ghanem C; Salinero AE; Kordit D; Mansour FM; Kelly RD; Venkataganesh H; Kyaw NR; Gannon OJ; Riccio D; Fredman G; Poitelon Y; Belin S; Kopec AM; Robison LS; Zuloaga KL
    Biol Sex Differ; 2023 May; 14(1):31. PubMed ID: 37208759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The angiotensin (1-7) glycopeptide PNA5 improves cognition in a chronic progressive mouse model of Parkinson's disease through modulation of neuroinflammation.
    Bernard K; Mota JA; Wene P; Corenblum MJ; Saez JL; Bartlett MJ; Heien ML; Doyle KP; Polt R; Hay M; Madhavan L; Falk T
    Exp Neurol; 2024 Nov; 381():114926. PubMed ID: 39153685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Menopause causes metabolic and cognitive impairments in a chronic cerebral hypoperfusion model of vascular contributions to cognitive impairment and dementia.
    Gannon OJ; Naik JS; Riccio D; Mansour FM; Abi-Ghanem C; Salinero AE; Kelly RD; Brooks HL; Zuloaga KL
    Biol Sex Differ; 2023 May; 14(1):34. PubMed ID: 37221553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease.
    Mattsson N; Cullen NC; Andreasson U; Zetterberg H; Blennow K
    JAMA Neurol; 2019 Jul; 76(7):791-799. PubMed ID: 31009028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement C3a Receptor (C3aR) Mediates Vascular Dysfunction, Hippocampal Pathology, and Cognitive Impairment in a Mouse Model of VCID.
    Bhatia K; Kindelin A; Nadeem M; Khan MB; Yin J; Fuentes A; Miller K; Turner GH; Preul MC; Ahmad AS; Mufson EJ; Waters MF; Ahmad S; Ducruet AF
    Transl Stroke Res; 2022 Oct; 13(5):816-829. PubMed ID: 35258803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex-specific effects of high-fat diet on cognitive impairment in a mouse model of VCID.
    Salinero AE; Robison LS; Gannon OJ; Riccio D; Mansour F; Abi-Ghanem C; Zuloaga KL
    FASEB J; 2020 Nov; 34(11):15108-15122. PubMed ID: 32939871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular cognitive impairment: Modeling a critical neurologic disease in vitro and in vivo.
    Helman AM; Murphy MP
    Biochim Biophys Acta; 2016 May; 1862(5):975-82. PubMed ID: 26704178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive impairment in heart failure: A protective role for angiotensin-(1-7).
    Hay M; Vanderah TW; Samareh-Jahani F; Constantopoulos E; Uprety AR; Barnes CA; Konhilas J
    Behav Neurosci; 2017 Feb; 131(1):99-114. PubMed ID: 28054808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular risk, gait, behavioral, and plasma indicators of VCID.
    Raghavan S; Przybelski SA; Lesnick TG; Fought AJ; Reid RI; Gebre RK; Windham BG; Algeciras-Schimnich A; Machulda MM; Vassilaki M; Knopman DS; Jack CR; Petersen RC; Graff-Radford J; Vemuri P
    Alzheimers Dement; 2024 Feb; 20(2):1201-1213. PubMed ID: 37932910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurofilament light chain protein in neurodegenerative dementia: A systematic review and network meta-analysis.
    Zhao Y; Xin Y; Meng S; He Z; Hu W
    Neurosci Biobehav Rev; 2019 Jul; 102():123-138. PubMed ID: 31026486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Needle Mouse Model of Vascular Cognitive Impairment and Dementia.
    Weng Z; Cao C; Stepicheva NA; Chen F; Foley LM; Cao S; Bhuiyan MIH; Wang Q; Wang Y; Hitchens TK; Sun D; Cao G
    J Neurosci; 2023 Nov; 43(44):7351-7360. PubMed ID: 37684030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma Concentrations of Neurofilament Light Chain Protein and Brain-Derived Neurotrophic Factor as Consistent Biomarkers of Cognitive Impairment in Alcohol Use Disorder.
    Requena-Ocaña N; Araos P; Serrano-Castro PJ; Flores-López M; García-Marchena N; Oliver-Martos B; Ruiz JJ; Gavito A; Pavón FJ; Serrano A; Mayoral F; Suarez J; Fonseca FR
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease.
    Mattsson N; Andreasson U; Zetterberg H; Blennow K;
    JAMA Neurol; 2017 May; 74(5):557-566. PubMed ID: 28346578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory microRNAs and vascular cognitive impairment and dementia.
    Zhang J; Sun P; Zhou C; Zhang X; Ma F; Xu Y; Hamblin MH; Yin KJ
    CNS Neurosci Ther; 2020 Dec; 26(12):1207-1218. PubMed ID: 33459504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated Levels of Serum Neurofilament Light Chain Associated with Cognitive Impairment in Vascular Dementia.
    Ma W; Zhang J; Xu J; Feng D; Wang X; Zhang F
    Dis Markers; 2020; 2020():6612871. PubMed ID: 33204362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-Parametric Classification of Vascular Cognitive Impairment and Dementia: The Impact of Diverse Cerebrovascular Injury Biomarkers.
    Lang B; Kindy MS; Kozel FA; Schultz SK; Taheri S
    J Alzheimers Dis; 2018; 62(1):39-60. PubMed ID: 29439338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.